81 related articles for article (PubMed ID: 23668401)
1. Alendronate sodium.
Ananchenko G; Novakovic J; Tikhomirova A
Profiles Drug Subst Excip Relat Methodol; 2013; 38():1-33. PubMed ID: 23668401
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and study of alendronate derivatives as potential prodrugs of alendronate sodium for the treatment of low bone density and osteoporosis.
Vachal P; Hale JJ; Lu Z; Streckfuss EC; Mills SG; MacCoss M; Yin DH; Algayer K; Manser K; Kesisoglou F; Ghosh S; Alani LL
J Med Chem; 2006 Jun; 49(11):3060-3. PubMed ID: 16722624
[TBL] [Abstract][Full Text] [Related]
3. Gastroresistant microparticles containing sodium alendronate prevent the bone loss in ovariectomized rats.
Cruz L; Assumpção E; Andrade SF; Conrado DJ; Kulkamp IC; Guterres SS; Pohlmann AR
Eur J Pharm Sci; 2010 Aug; 40(5):441-7. PubMed ID: 20471479
[TBL] [Abstract][Full Text] [Related]
4. Ab initio structure determination of anhydrous sodium alendronate from laboratory powder X-ray diffraction data.
Asnani M; Vyas K; Bhattacharya A; Devarakonda S; Chakraborty S; Mukherjee AK
J Pharm Sci; 2009 Jun; 98(6):2113-21. PubMed ID: 18781644
[TBL] [Abstract][Full Text] [Related]
5. Rapid determination of alendronate to quality evaluation of tablets by high resolution ¹H NMR spectroscopy.
Xie B; Liu A; Fang X; Chen Y; Zhong H
J Pharm Biomed Anal; 2014 May; 93():73-6. PubMed ID: 24215933
[TBL] [Abstract][Full Text] [Related]
6. In vitro determination of the release of alendronic acid from alendronate tablets of different brands during deglutition.
Lamprecht G
J Pharm Sci; 2009 Oct; 98(10):3575-81. PubMed ID: 19630066
[TBL] [Abstract][Full Text] [Related]
7. Electrospray tandem mass spectrometry of alendronate analogues: fingerprints for characterization of new potential prodrugs.
Hardouin J; Guénin E; Malosse C; Caron M; Lecouvey M
Rapid Commun Mass Spectrom; 2008 Aug; 22(15):2287-300. PubMed ID: 18613280
[TBL] [Abstract][Full Text] [Related]
8. In vitro disintegration and dissolution and in vivo bioequivalence of two alendronate once-weekly formulations.
Almeida S; Almeida A; Filipe A; Penedo C; Rocha A; Lainesse A; Vallée F
Arzneimittelforschung; 2006; 56(2):84-9. PubMed ID: 16572922
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vivo bioactivity of lipophilic alendronate derivatives against osteoporosis.
Lu TL; Hu HJ; Zhao W; Chen T
Drug Dev Ind Pharm; 2011 Jun; 37(6):656-63. PubMed ID: 21449707
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of novel bone-targeting dual-action pro-drugs for the treatment and reversal of osteoporosis.
Arns S; Gibe R; Moreau A; Monzur Morshed M; Young RN
Bioorg Med Chem; 2012 Mar; 20(6):2131-40. PubMed ID: 22341574
[TBL] [Abstract][Full Text] [Related]
11. N⁴-[Alkyl-(hydroxyphosphono)phosphonate]-cytidine-new drugs covalently linking antimetabolites (5-FdU, araU or AZT) with bone-targeting bisphosphonates (alendronate or pamidronate).
Schott H; Goltz D; Schott TC; Jauch C; Schwendener RA
Bioorg Med Chem; 2011 Jun; 19(11):3520-6. PubMed ID: 21536448
[TBL] [Abstract][Full Text] [Related]
12. Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled, exploratory study.
Adachi JD; Faraawi RY; O'Mahony MF; Nayar A; Massaad R; Evans JK; Yacik C
Clin Ther; 2009 Aug; 31(8):1747-53. PubMed ID: 19808133
[TBL] [Abstract][Full Text] [Related]
13. Process analytical technology to understand the disintegration behavior of alendronate sodium tablets.
Xu X; Gupta A; Sayeed VA; Khan MA
J Pharm Sci; 2013 May; 102(5):1513-23. PubMed ID: 23450666
[TBL] [Abstract][Full Text] [Related]
14. Alendronate and Pamidronate calcium phosphate bone cements: setting properties and in vitro response of osteoblast and osteoclast cells.
Panzavolta S; Torricelli P; Bracci B; Fini M; Bigi A
J Inorg Biochem; 2009 Jan; 103(1):101-6. PubMed ID: 18977031
[TBL] [Abstract][Full Text] [Related]
15. Understanding the influence of alendronate on the morphology and phase transformation of apatitic precursor nanocrystals.
Zhang G; Huang R; Li Z; Yang X; Chen X; Xia W; Sun X; Yang G; Gao C; Gou Z
J Inorg Biochem; 2012 Aug; 113():1-8. PubMed ID: 22687488
[TBL] [Abstract][Full Text] [Related]
16. The absorption of (99m)Tc-alendronate given by rectal route in rabbits.
Asikoğlu M; Ozguney I; Ozcan I; Orumlu O; Guneri T; Koseoğlu K; Ozkilic H
Pharm Dev Technol; 2008; 13(3):213-20. PubMed ID: 18484490
[TBL] [Abstract][Full Text] [Related]
17. Enteric-coated alendronate sodium nanoliposomes: a novel formula to overcome barriers for the treatment of osteoporosis.
Hosny KM; Ahmed OA; Al-Abdali RT
Expert Opin Drug Deliv; 2013 Jun; 10(6):741-6. PubMed ID: 23656470
[TBL] [Abstract][Full Text] [Related]
18. High-performance liquid chromatography method for determining alendronate sodium in human plasma by detecting fluorescence: application to a pharmacokinetic study in humans.
Yun MH; Kwon KI
J Pharm Biomed Anal; 2006 Jan; 40(1):168-72. PubMed ID: 16095861
[TBL] [Abstract][Full Text] [Related]
19. Studies on the formation of hydrophobic ion-pairing complex of alendronate.
You SK; Kwon HH; Lee JM; Shin SC; Cho CW
Arch Pharm Res; 2009 Jul; 32(7):1055-60. PubMed ID: 19641887
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.
Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS
Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
